KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

90 hedge funds and large institutions have $95.2M invested in Chinook Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 28 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+8
Holders Change %
+9.76%
% of All Funds
1.85%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
28
Reduced
20
Closed
15
Calls
$608K
Puts
$11K
Net Calls
+$597K
Net Calls Change
+$362K

Top Buyers

1
SCM
Suvretta Capital Management
New York
$1.86M
2
RCMNY
Rubric Capital Management (New York)
New York
$3.76M
3
PPA
Parametric Portfolio Associates
Washington
$808K
4
Wells Fargo
Wells Fargo
California
$917K
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
$594K

Top Sellers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
$0
2
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$2.42M
3
IC
Ikarian Capital
Texas
$7.79M
4
EAM
Erste Asset Management
Austria
$2.24M
5
Millennium Management
Millennium Management
New York
$27K
Name Holding Trade Value Shares
Change 		Shares
Change %
AIM
101
Alambic Investment Management
California
– -$29K -2,140 Closed
MLICM
102
Metropolitan Life Insurance Company (MetLife)
New York
– -$14.4K -1,049 Closed
Federated Hermes
103
Federated Hermes
Pennsylvania
– -$2K -123 Closed
EI
104
Ellevest Inc
New York
– -$1K -93 Closed
1 2 3 4
5